As Xue et al. (2013) reported increased antitumor activity of tumor-redirected CD4 T cells when co-transduced with the CD8-receptor, we cannot exclude that observed limitations of our tgCD4 T cells could be attributed to the lack CD8-co-expression [27]. This evidence concerns the gene CD8A and neoplasm.